Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SFOSF research report →
Price Chart
About the company
Shanghai Fosun Pharmaceutical (Group) Co. , Ltd. (SFOSF), founded in 1994 and based in Shanghai, China, is a comprehensive pharmaceutical enterprise.
- CEO
- Yi Liu
- IPO
- 2014
- Employees
- 40,603
- HQ
- Shanghai, SH, CN
Get TickerSpark's AI analysis on SFOSF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $6.48B
- P/E
- 18.56
- Fwd P/E
- 1.61
- PEG
- 4.57
- P/S
- 1.47
- P/B
- 1.29
- EV/EBITDA
- 13.45
- Div Yield
- 1.64%
- Gross Margin
- 48.92%
- Op Margin
- 7.41%
- Net Margin
- 7.96%
- ROE
- 6.97%
- ROIC
- 2.45%
Latest fiscal year · YoY change
- Revenue
- $40.43B-1.6%
- Gross Profit
- $20.16B+2.3%
- Op Income
- $2.54B
- Net Income
- $3.28B+18.5%
- EPS
- $1.26+21.2%
- OCF Growth
- +16.4%
- FCF Growth
- +1045.0%
- 52W High
- $3.30
- 52W Low
- $1.93
- 50D MA
- $2.20
- 200D MA
- $2.41
- Beta
- 0.44
- RSI (14)
- 75
- Avg Volume
- 110
No earnings-call transcripts are available for SFOSF yet.
- Free Float
- 35.5%
- Shares Outstanding
- 2.65B
- Float Shares
- 940.83M
Our SFOSF coverage
Recent articles, reports, and earnings notes.
No research on SFOSF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SFOSF report →Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) Q2 2026 Earnings Call Transcript
seekingalpha.com · Sep 28
Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion
prnewswire.com · Sep 6
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Short Interest Up 21.2% in January
defenseworld.net · Feb 19
Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse
reuters.com · Aug 31
Fosun Pharma Shares Gain After Tie-Up With New Covid Drug Supplier Genuine Biotech
forbes.com · Jul 25
Week In Review: Nuance In-Licenses RSV Vaccine In $225 Million Deal
seekingalpha.com · Mar 27
Pandemic Accelerates China's Drive Into mRNA Treatments
seekingalpha.com · Jun 18
Week In Review: Genscript And Its Legend Bio Subsidiary Raise $1 Billion From Hillhouse
seekingalpha.com · May 16
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.